348 related articles for article (PubMed ID: 8345202)
1. Recombinant tetravalent group A streptococcal M protein vaccine.
Dale JB; Chiang EY; Lederer JW
J Immunol; 1993 Aug; 151(4):2188-94. PubMed ID: 8345202
[TBL] [Abstract][Full Text] [Related]
2. Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses.
Bronze MS; Courtney HS; Dale JB
J Immunol; 1992 Feb; 148(3):888-93. PubMed ID: 1370521
[TBL] [Abstract][Full Text] [Related]
3. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes.
Bessen D; Fischetti VA
J Immunol; 1990 Aug; 145(4):1251-6. PubMed ID: 1696296
[TBL] [Abstract][Full Text] [Related]
4. Sequence and type-specific immunogenicity of the amino-terminal region of type 1 streptococcal M protein.
Kraus W; Haanes-Fritz E; Cleary PP; Seyer JM; Dale JB; Beachey EH
J Immunol; 1987 Nov; 139(9):3084-90. PubMed ID: 2444650
[TBL] [Abstract][Full Text] [Related]
5. Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain.
Bronze MS; Dale JB
J Immunol; 1993 Sep; 151(5):2820-8. PubMed ID: 7689617
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers.
McNeil SA; Halperin SA; Langley JM; Smith B; Warren A; Sharratt GP; Baxendale DM; Reddish MA; Hu MC; Stroop SD; Linden J; Fries LF; Vink PE; Dale JB
Clin Infect Dis; 2005 Oct; 41(8):1114-22. PubMed ID: 16163629
[TBL] [Abstract][Full Text] [Related]
7. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.
Yoonim N; Olive C; Pruksachatkunakorn C; Pruksakorn S
BMC Microbiol; 2006 Aug; 6():71. PubMed ID: 16895610
[TBL] [Abstract][Full Text] [Related]
8. Structure-based design of broadly protective group a streptococcal M protein-based vaccines.
Dale JB; Smeesters PR; Courtney HS; Penfound TA; Hohn CM; Smith JC; Baudry JY
Vaccine; 2017 Jan; 35(1):19-26. PubMed ID: 27890396
[TBL] [Abstract][Full Text] [Related]
9. Mapping a conserved conformational epitope from the M protein of group A streptococci.
Relf WA; Cooper J; Brandt ER; Hayman WA; Anders RF; Pruksakorn S; Currie B; Saul A; Good MF
Pept Res; 1996; 9(1):12-20. PubMed ID: 8727479
[TBL] [Abstract][Full Text] [Related]
10. Epitopes of group A streptococcal M protein shared with antigens of articular cartilage and synovium.
Baird RW; Bronze MS; Kraus W; Hill HR; Veasey LG; Dale JB
J Immunol; 1991 May; 146(9):3132-7. PubMed ID: 2016540
[TBL] [Abstract][Full Text] [Related]
11. Synthetic peptide fragments of streptococcal M proteins.
Seyer JM; Dale JB; Beachey EH
Dev Biol Stand; 1986; 63():101-8. PubMed ID: 2427375
[TBL] [Abstract][Full Text] [Related]
12. Protective and nonprotective epitopes of chemically synthesized peptides of the NH2-terminal region of type 6 streptococcal M protein.
Beachey EH; Seyer JM
J Immunol; 1986 Mar; 136(6):2287-92. PubMed ID: 2419429
[TBL] [Abstract][Full Text] [Related]
13. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.
Brandt ER; Sriprakash KS; Hobb RI; Hayman WA; Zeng W; Batzloff MR; Jackson DC; Good MF
Nat Med; 2000 Apr; 6(4):455-9. PubMed ID: 10742155
[TBL] [Abstract][Full Text] [Related]
14. Sequence of protective epitopes of streptococcal M proteins shared with cardiac sarcolemmal membranes.
Sargent SJ; Beachey EH; Corbett CE; Dale JB
J Immunol; 1987 Aug; 139(4):1285-90. PubMed ID: 2440952
[TBL] [Abstract][Full Text] [Related]
15. Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments.
Dale JB
Vaccine; 1999 Jan; 17(2):193-200. PubMed ID: 9987154
[TBL] [Abstract][Full Text] [Related]
16. Surface-exposed conserved region of the streptococcal M protein induces antibodies cross-reactive with denatured forms of myosin.
Vashishtha A; Fischetti VA
J Immunol; 1993 May; 150(10):4693-701. PubMed ID: 8482854
[TBL] [Abstract][Full Text] [Related]
17. Conserved T and B cell epitopes on the M protein of group A streptococci. Induction of bactericidal antibodies.
Pruksakorn S; Galbraith A; Houghten RA; Good MF
J Immunol; 1992 Oct; 149(8):2729-35. PubMed ID: 1383324
[TBL] [Abstract][Full Text] [Related]
18. Binding of human plasma proteins to Streptococcus pyogenes M protein determines the location of opsonic and non-opsonic epitopes.
Sandin C; Carlsson F; Lindahl G
Mol Microbiol; 2006 Jan; 59(1):20-30. PubMed ID: 16359315
[TBL] [Abstract][Full Text] [Related]
19. Recombinant, octavalent group A streptococcal M protein vaccine.
Dale JB; Simmons M; Chiang EC; Chiang EY
Vaccine; 1996 Jul; 14(10):944-8. PubMed ID: 8873386
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of a 26-valent group A streptococcal vaccine.
Hu MC; Walls MA; Stroop SD; Reddish MA; Beall B; Dale JB
Infect Immun; 2002 Apr; 70(4):2171-7. PubMed ID: 11895984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
